anti-PD1 antibody (unspecified)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for anti-PD1 antibody (unspecified), covering 2026-03-31 to 2026-03-31. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Test How Well Different Doses of BI 1831169 in Combination With an Anti-PD1 Antibody Are Tolerated in Japanese People With Different Advanced Cancers [Phase 1]